In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. (Q37637750)
Jump to navigation
Jump to search
scientific article published on March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. |
scientific article published on March 2014 |
Statements
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects (English)
S Ghosh
M S Crowe
S G Kinsey
M J Niphakis
R A Abdullah
Q Tao
D M Walentiny
B F Cravatt